CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $1.86B, above the global median of $1.15B
- FinancialsAltman Z-Score 4.92: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.68%
Annual Rate
CNY 0.43Paid annual
Payout Ratio
46.7%Sustainable
Payback Period
36.4 yr
Last Ex-Dividend
May 29, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
12.52BCNY1.86B · vs all stocks (USD)
Trailing P/E
17.61xRevenue (TTM)
6.13BCNY911.23M · vs all stocks (USD)
Profit Margin
11.53%Beta
0.1960xvs all stocks
52-Week Change
-3.11%vs all stocks
Market Capitalization
12.52BCNY1.86B · vs all stocks (USD)
Enterprise Value
10.64BCNY1.58B · vs all stocks (USD)
Trailing P/E
17.61xPrice to Sales (TTM)
2.07xPrice to Book (MRQ)
1.49xEnterprise to Revenue
1.74xEnterprise to EBITDA
8.16xGross Margin
24.44%Profit Margin
11.53%Operating Margin
12.65%Return on Assets (TTM)
4.60%Return on Equity (TTM)
8.56%Revenue (TTM)
6.13BCNY911.23M · vs all stocks (USD)
Revenue per Share (TTM)
7.94CNYUpdated Aug 20, 2026Quarterly Revenue Growth
2.20%Gross Profit (TTM)
1.46BCNY217.48M · vs all stocks (USD)
EBITDA (TTM)
874.81MCNY130.09M · vs all stocks (USD)
Net Income (TTM)
706.60MCNY105.08M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-24.90%Operating Cash Flow (TTM)
911.35MCNY135.53M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
515.37MCNY76.64M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.4286CNYUpdated Aug 20, 2026Trailing Annual Dividend Yield
2.68%vs all stocks
Payout Ratio
46.73%Minority Interest (Equity)
2.43MCNYFY2025 · Dec 31, 2025Revenue
6.01BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
4.45BCNYFY2025 · Dec 31, 2025Gross Profit
1.56BCNYFY2025 · Dec 31, 2025Operating Income
961.88MCNY143.04M · vs all stocks (USD)
Pre-tax Income
951.26MCNYFY2025 · Dec 31, 2025Income Tax Expense
133.69MCNYFY2025 · Dec 31, 2025Net Income
817.57MCNYFY2025 · Dec 31, 2025EBIT
975.18MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
1.45BCNYFY2025 · Dec 31, 2025Research & Development
209.83MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
138.71MCNYFY2025 · Dec 31, 2025Other Operating Expenses
57.84MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
17.57MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
23.92MCNYFY2025 · Dec 31, 2025EPS (Basic)
1.48CNYFY2025 · Dec 31, 2025EPS (Diluted)
1.48CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
554.61MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
554.61MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
817.57MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
3.25MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
653.24MCNYFY2025 · Dec 31, 2025Free Cash Flow
399.63MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.12BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
817.57MCNYFY2025 · Dec 31, 2025Other Non-cash Items
24.96MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
258.28MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-447.57MCNYFY2025 · Dec 31, 2025Capital Expenditures
-253.61MCNYFY2025 · Dec 31, 2025Purchase of Investments
-15.97BCNYFY2025 · Dec 31, 2025Sale of Investments
15.37BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-851.46MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
1.03BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-813.79MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-359.63MCNYFY2025 · Dec 31, 2025Other Financing Charges
18.44MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-122.95MCNYFY2025 · Dec 31, 2025Shares Outstanding
782.35MSharesUpdated Aug 20, 2026Float Shares
313.04MSharesUpdated Aug 20, 2026% Held by Insiders
63.51%vs all stocks
% Held by Institutions
4.16%vs all stocks
Total Cash (MRQ)
2.51BCNY373.92M · vs all stocks (USD)
Total Cash per Share (MRQ)
3.26CNYUpdated Aug 20, 2026Total Debt (MRQ)
1.03BCNY152.75M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1223xCurrent Ratio (MRQ)
2.33xBook Value per Share (MRQ)
10.88CNYUpdated Aug 20, 2026Total Assets
10.98BCNY1.63B · vs all stocks (USD)
Total Current Assets
6.11BCNYFY2025 · Dec 31, 2025Total Liabilities
2.43BCNYFY2025 · Dec 31, 2025Total Non-current Assets
4.87BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
507.82MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.92BCNYFY2025 · Dec 31, 2025Cash
1.34BCNYFY2025 · Dec 31, 2025Cash Equivalents
122.13MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.46BCNYFY2025 · Dec 31, 2025Other Short-term Investments
1.24BCNYFY2025 · Dec 31, 2025Accounts Receivable
859.33MCNYFY2025 · Dec 31, 2025Inventory
1.78BCNYFY2025 · Dec 31, 2025Accounts Payable
1.20BCNYFY2025 · Dec 31, 2025Short-term Debt
513.39MCNYFY2025 · Dec 31, 2025Other Current Liabilities
1.54MCNYFY2025 · Dec 31, 2025Long-term Debt
478.01MCNYFY2025 · Dec 31, 2025Common Stock (Book)
558.82MCNYFY2025 · Dec 31, 2025Retained Earnings
4.13BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
8.56BCNY1.27B · vs all stocks (USD)
52-Week Low
14.34CNYUpdated Aug 20, 202652-Week High
21.41CNYUpdated Aug 20, 202652-Week Change
-3.11%vs all stocks
Beta
0.1960xvs all stocks
50-Day MA
15.68CNYUpdated Aug 20, 2026200-Day MA
17.30CNYUpdated Aug 20, 2026Avg 10-Day Volume
7.05MSharesUpdated Aug 20, 2026Avg 30-Day Volume
7.60MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
0.9200CNYUpdated Aug 20, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 4.92: safe zoneNotable
Altman Z-Score: 4.92
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $1.86B, above the global median of $1.15BNotable
Market cap (USD): 1,861,499,196.144Global Median: 1,146,734,693.424
Revenue is $911.23M, above the global median of $520.53MNotable
Revenue (USD): 911,226,811.269Global Median: 520,528,949.311
Levered free cash flow is $76.64M, above the global median of $16.24MNotable
Levered free cash flow (USD): 76,640,427.626Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Yifan Pharmaceutical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Jafron Biomedical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Zenas BioPharma, Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
UFP Technologies Inc.
Tier 1ProductionApproval-Gated PipelineRule
Hunan Jingfeng Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Mirxes Holding Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Cohance Lifesciences Limited
Tier 1ProductionApproval-Gated PipelineRule
Ascletis Pharma Inc.
Tier 1ProductionApproval-Gated PipelineRule
Nanjing Vazyme Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Novocure Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Hubei Jumpcan Pharmaceutical Co., Ltd.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
CIE Automotive India Ltd.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Manhattan Associates Inc.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities